Zevra therapeutics to participate in rare disease panel at the 2024 maxim healthcare virtual summit, presented by maxim group llc

Celebration, fla., oct. 10, 2024 (globe newswire) -- zevra therapeutics, inc. (nasdaqgs: zvra) (zevra, or the company), a rare disease therapeutics company, today announced that neil f. mcfarlane, president and chief executive office of zevra, will participate in a rare disease panel at the 2024 maxim healthcare virtual summit, presented by maxim group llc on thursday, october 17, 2024 at 2 p.m. et.
ZVRA Ratings Summary
ZVRA Quant Ranking